A candidate drug for people with early Alzheimer’s disease slowed cognitive decline by about 27% over 18 months, according to a report on a phase 3 trial published in the New England Journal of Medicine on Tuesday. Lecanemab is a monoclonal antibody that is given as an intravenous infusion every two weeks, and targets a […] Continue reading ->
South Korea became the first country in the world to achieve the highest level, “maturity level 4” (ML4), in regulating medicines and vaccines.  The Ministry of Food and Drug Safety (MFDS) in the Republic of Korea is the only national regulatory authority to be recognised by the World Health Organization (WHO) to have advanced oversight […] Continue reading ->
Stronger international rules and cooperation mechanisms on health are at the heart of the European Union’s new global health strategy, which was launched on Wednesday.  The strategy is based on three priorities: ensuring that people stay well throughout their lives, strengthening health systems particularly by advancing universal health coverage, and applying a ‘One Health’ approach […] Continue reading ->